Azzad Asset Management Inc. ADV bought a new position in National Research Co. (NASDAQ:NRC - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 33,314 shares of the company's stock, valued at approximately $426,000. Azzad Asset Management Inc. ADV owned about 0.15% of National Research at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Principal Financial Group Inc. increased its holdings in shares of National Research by 10.7% in the fourth quarter. Principal Financial Group Inc. now owns 12,018 shares of the company's stock valued at $212,000 after purchasing an additional 1,161 shares during the period. Bank of New York Mellon Corp boosted its holdings in National Research by 88.5% in the fourth quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company's stock valued at $3,832,000 after purchasing an additional 101,957 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in National Research during the 4th quarter worth about $283,000. Norden Group LLC purchased a new position in shares of National Research during the 4th quarter valued at about $182,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of National Research by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 124,711 shares of the company's stock valued at $2,200,000 after buying an additional 970 shares during the period. Institutional investors and hedge funds own 47.26% of the company's stock.
Insider Buying and Selling
In other National Research news, major shareholder Patrick E. Beans purchased 2,500 shares of National Research stock in a transaction that occurred on Monday, May 12th. The stock was bought at an average price of $13.59 per share, with a total value of $33,975.00. Following the acquisition, the insider now owns 35,003 shares of the company's stock, valued at $475,690.77. This trade represents a 7.69% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 8.10% of the stock is currently owned by insiders.
National Research Stock Performance
Shares of NRC traded up $0.06 during mid-day trading on Tuesday, reaching $16.69. The company had a trading volume of 8,457 shares, compared to its average volume of 88,656. The stock has a market capitalization of $380.28 million, a P/E ratio of 15.90 and a beta of 0.38. National Research Co. has a 52-week low of $9.76 and a 52-week high of $27.07. The stock has a 50 day moving average of $13.00 and a two-hundred day moving average of $15.17. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30.
National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings results on Monday, April 28th. The company reported $0.25 earnings per share (EPS) for the quarter. The company had revenue of $33.55 million during the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.
National Research Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date of this dividend is Friday, June 27th. National Research's dividend payout ratio (DPR) is presently 46.60%.
About National Research
(
Free Report)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Featured Articles
Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
